IL-1R1 promoter complex in the neuroendocrine, nervous, and immune systems
神经内分泌、神经和免疫系统中的 IL-1R1 启动子复合物
基本信息
- 批准号:8079335
- 负责人:
- 金额:$ 8.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-06 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAmino Acid SequenceAnti-Inflammatory AgentsAnti-inflammatoryAntigen PresentationArthritisAttenuatedAutoimmune DiseasesBehaviorBinding SitesBiologicalBiological AssayBiologyBrain IschemiaCREB1 geneCell LineCellsCellular ImmunityCharacteristicsComplexDatabasesDevelopmentDiseaseExonsFeverFoundationsGenbankGenesGeneticGenetic TranscriptionGlucocorticoid ReceptorGlucocorticoidsHandHormonesHost DefenseHumanHypothalamic structureImmune responseImmune systemIn Situ HybridizationInfectious AgentInflammationInflammatoryInterleukin-1Interleukin-1 ReceptorsKnowledgeLaboratoriesLeadLearningLocationLymphocyte ActivationMapsMediatingMemoryMessenger RNAMusNeuronsNeurosecretory SystemsNeurotransmittersNucleic Acid Regulatory SequencesPathogenesisPatternPeptidesPhasePhenotypePhysiologicalPlayProcessPromoter RegionsRNA SplicingRegulationRegulatory ElementResearchRoleScreening procedureSignaling MoleculeStagingStressStructureSympathetic Nervous SystemSystemTissuesTranscription Initiation SiteTranscriptional RegulationWorkbasecell typeconditioned feardeletion analysisgenetic elementin vivointerleukin-1 receptor type Iinterleukin-1 receptor type IInerve injurypromoterreceptorresponsetranscription factor
项目摘要
DESCRIPTION (provided by applicant): Type I interleukin-1 receptor (IL-1R1) is the functional receptor for IL-1. IL-1 mediates numerous activities in the neuroendocrine, nervous, and immune systems. The transcriptional regulation of IL-1R1 is poorly understood. Current work in our lab has identified three promoters that control the transcription of IL-1R1 in mouse. The activities of these IL-1R1 promoters are tissue-specific, cell type-specific and dependent on developmental stages. In addition, these promoters are found to be regulated by exogenous as well as endogenous genetic regulatory elements. In vivo, the activities of the three murine IL-1R1 promoters showed distinct distribution patterns. Further, these IL-1R1 promoters are differentially regulated by signaling molecules, such as glucocorticoids. A species comparison study between murine and human IL-1R1 structures has been conducted. Aligning the resulting human and murine IL-1R1 promoter regions revealed a conserved framework by which IL-1R1 gene in both species are likely to be regulated by conserved regulatory sequences. These preliminary discoveries lead us to define a genetic region termed IL-1R1 promoter complex. The central hypotheses of this application are: 1) the level and type of IL-1R1 mRNAs expressed in a given cell are regulated by the IL-1R1 promoter complex; 2) the transcriptional control mechanisms in the IL-1R1 promoter complex determine the tissue- and cell type-specific expression of IL-1R1; and 3) IL-1R1 promoter complex contributes to the precise response characteristics of IL-1R1-bearing cells when they are stimulated by signaling molecules. We will pursue the following specific aims: 1) Determine the pattern of distribution of the promoter-specific IL-1R1 expression; 2) Elucidate transcriptional control mechanisms of the IL-1R1 promoter complex; and 3) Investigate promoter activity of IL-1R1 gene in selected cell types after the cells are stimulated by different signaling molecules. The results will reveal the transcriptional mechanisms that allow tissue-specific and cell type-specific expression and regulation of IL-1R1 that may be critical for the vast diversity of IL-1R1 function in multiple systems. This study will contribute significantly to IL-1R1 biology and provide a new foundation for our understanding of how IL-1R1 transcription might be involved in pathogenesis. for "IL-1R1 promoter complex in the neuroendocrine, nervous, and immune system" This study investigates the transcriptional mechanisms that control the expression of the type 1 interleukin-1 receptor. This receptor is important for many functions in the nervous, neuroendocrine, and immune systems. The results will provide a foundation for the understanding of how dysregulation of the expression of type 1 interleukin-1 receptor may be involved in the pathogenesis of diseases in multiple systems.
描述(由申请人提供):I型白介素-1受体(IL-1R1)是IL-1的功能性受体。IL-1介导神经内分泌、神经和免疫系统的许多活动。IL-1R1的转录调控尚不清楚。我们实验室目前的工作已经确定了三种控制小鼠IL-1R1转录的启动子。这些IL-1R1启动子的活性具有组织特异性、细胞类型特异性和发育阶段依赖性。此外,这些启动子被发现受到外源和内源遗传调控元件的调控。在体内,三种小鼠IL-1R1启动子的活性表现出不同的分布模式。此外,这些IL-1R1启动子受到信号分子(如糖皮质激素)的差异调节。我们进行了鼠与人IL-1R1结构的物种比较研究。比对得到的人和小鼠IL-1R1启动子区域揭示了一个保守的框架,这两个物种的IL-1R1基因可能受到保守的调控序列的调控。这些初步发现使我们确定了一个称为IL-1R1启动子复合物的遗传区域。该应用的中心假设是:1)在给定细胞中表达的IL-1R1 mrna的水平和类型由IL-1R1启动子复合物调节;2) IL-1R1启动子复合体的转录调控机制决定了IL-1R1的组织和细胞特异性表达;3) IL-1R1启动子复合物有助于IL-1R1承载细胞在受到信号分子刺激时的精确响应特性。我们将追求以下具体目标:1)确定启动子特异性IL-1R1表达的分布模式;2)阐明IL-1R1启动子复合物的转录调控机制;3)研究不同信号分子刺激细胞后IL-1R1基因启动子活性。这些结果将揭示IL-1R1的组织特异性和细胞类型特异性表达和调控的转录机制,这可能是多种系统中IL-1R1功能多样性的关键。本研究将对IL-1R1的生物学研究做出重要贡献,并为我们了解IL-1R1转录如何参与发病机制提供新的基础。本研究探讨了控制1型白介素-1受体表达的转录机制。这种受体对神经、神经内分泌和免疫系统的许多功能都很重要。该结果将为理解1型白细胞介素-1受体表达失调如何参与多系统疾病的发病机制提供基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ning Quan其他文献
Ning Quan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ning Quan', 18)}}的其他基金
Dynamic regulation of neuroinflammation and IL-1b-trap
神经炎症和 IL-1b-trap 的动态调节
- 批准号:
10726269 - 财政年份:2023
- 资助金额:
$ 8.4万 - 项目类别:
Cell Specific Identification of IL-1R Actions in Acute and Chronic Pain
IL-1R 在急性和慢性疼痛中作用的细胞特异性鉴定
- 批准号:
10317169 - 财政年份:2021
- 资助金额:
$ 8.4万 - 项目类别:
Neuroinflammation, Neuronal IL-1R1, and Behavior
神经炎症、神经元 IL-1R1 和行为
- 批准号:
10586078 - 财政年份:2020
- 资助金额:
$ 8.4万 - 项目类别:
Neuroinflammation, Neuronal IL-1R1, and Behavior
神经炎症、神经元 IL-1R1 和行为
- 批准号:
10373034 - 财政年份:2020
- 资助金额:
$ 8.4万 - 项目类别:
IL-1R1-restore: dissecting cellular mechanisms of IL-1-mediated behavior effects
IL-1R1-restore:剖析 IL-1 介导的行为效应的细胞机制
- 批准号:
8428218 - 财政年份:2012
- 资助金额:
$ 8.4万 - 项目类别:
IL-1R1-restore: dissecting cellular mechanisms of IL-1-mediated behavior effects
IL-1R1-restore:剖析 IL-1 介导的行为效应的细胞机制
- 批准号:
8598110 - 财政年份:2012
- 资助金额:
$ 8.4万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 8.4万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 8.4万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 8.4万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 8.4万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 8.4万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 8.4万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 8.4万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 8.4万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 8.4万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 8.4万 - 项目类别: